Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Combination use of ranolazine with dofetilide for the maintenance of atrial fibrillation.

Shah SA, Koyama G, Da Costa D, McGregor P, Kolasa M.

Int J Cardiol. 2014 Apr 1;172(3):e428-9. doi: 10.1016/j.ijcard.2013.12.236. Epub 2014 Jan 10. No abstract available.

PMID:
24461967
2.

Ranolazine effectively suppresses atrial fibrillation in the setting of heart failure.

Burashnikov A, Di Diego JM, Barajas-Martínez H, Hu D, Cordeiro JM, Moise NS, Kornreich BG, Belardinelli L, Antzelevitch C.

Circ Heart Fail. 2014 Jul;7(4):627-33. doi: 10.1161/CIRCHEARTFAILURE.114.001129. Epub 2014 May 29. Erratum in: Circ Heart Fail. 2015 Jul;8(4):841. Zygmunt, Andy [removed].

3.

Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset atrial fibrillation.

Fragakis N, Koskinas KC, Katritsis DG, Pagourelias ED, Zografos T, Geleris P.

Am J Cardiol. 2012 Sep 1;110(5):673-7. doi: 10.1016/j.amjcard.2012.04.044. Epub 2012 May 22.

PMID:
22621799
4.

Second chance for dronedarone after recent setback?

Mullard A.

Lancet. 2012 Feb 18;379(9816):601. No abstract available.

PMID:
22355808
6.

Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.

Burashnikov A, Sicouri S, Di Diego JM, Belardinelli L, Antzelevitch C.

J Am Coll Cardiol. 2010 Oct 5;56(15):1216-24. doi: 10.1016/j.jacc.2010.08.600.

7.

Safety of oral dofetilide for rhythm control of atrial fibrillation and atrial flutter.

Abraham JM, Saliba WI, Vekstein C, Lawrence D, Bhargava M, Bassiouny M, Janiszewski D, Lindsay B, Militello M, Nissen SE, Poe S, Tanaka-Esposito C, Wolski K, Wilkoff BL.

Circ Arrhythm Electrophysiol. 2015 Aug;8(4):772-6. doi: 10.1161/CIRCEP.114.002339. Epub 2015 Jun 10.

PMID:
26063741
8.

Cardiovascular drugs. Dofetilide.

Mounsey JP, DiMarco JP.

Circulation. 2000 Nov 21;102(21):2665-70. Review. No abstract available.

9.

Ranolazine terminates atrial flutter and fibrillation in a canine model.

Bhimani AA, Yasuda T, Sadrpour SA, Khrestian CM, Lee S, Zeng D, Belardinelli L, Waldo AL.

Heart Rhythm. 2014 Sep;11(9):1592-9. doi: 10.1016/j.hrthm.2014.05.038. Epub 2014 Jun 2.

PMID:
25066042
10.
11.

Efficacy and safety of intravenous dofetilide for rapid termination of atrial fibrillation and atrial flutter.

Lindeboom JE, Kingma JH, Crijns HJ, Dunselman PH.

Am J Cardiol. 2000 Apr 15;85(8):1031-3. No abstract available.

PMID:
10760352
12.

[New developments in the antiarrhythmic therapy of atrial fibrillation].

Ravens U.

Herzschrittmacherther Elektrophysiol. 2014 Mar;25(1):41-6. doi: 10.1007/s00399-014-0302-1. Epub 2014 Feb 5. Review. German.

PMID:
24496483
13.

Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.

Milberg P, Frommeyer G, Ghezelbash S, Rajamani S, Osada N, Razvan R, Belardinelli L, Breithardt G, Eckardt L.

Europace. 2013 May;15(5):761-9. doi: 10.1093/europace/eus399. Epub 2013 Feb 1.

15.

Refractory atrial fibrillation effectively treated with ranolazine.

Vaishnav A, Vaishnav A, Lokhandwala Y.

Indian Heart J. 2014 Jan-Feb;66(1):115-8. doi: 10.1016/j.ihj.2013.12.024. Epub 2014 Jan 4. Review.

16.

Evaluation of KCB-328, a new IKr blocking antiarrhythmic agent in pacing induced canine atrial fibrillation.

Chandra P, Rosen TS, Yeom ZH, Lee K, Kim HY, Danilo P Jr, Rosen MR.

Europace. 2004 Sep;6(5):384-91.

17.

Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation.

Coleman CI, Sood N, Chawla D, Talati R, Ghatak A, Kluger J; Dofetilide and Intravenous Magnesium Evaluation (DIME) Investigators.

Europace. 2009 Jul;11(7):892-5. doi: 10.1093/europace/eup084. Epub 2009 Apr 6.

18.

Amiodarone and atrial fibrillation.

London B.

J Cardiovasc Electrophysiol. 2007 Dec;18(12):1321-2. Epub 2007 Oct 24. No abstract available.

PMID:
17971150
20.

Electrocardiographic markers of repolarization heterogeneity during dofetilide or sotalol initiation for paroxysmal atrial fibrillation.

Sauer AJ, Kaplan R, Xue J, Dorsey P, Hayes M, Shah SJ, Passman R.

Am J Cardiol. 2014 Jun 15;113(12):2030-5. doi: 10.1016/j.amjcard.2014.03.047. Epub 2014 Apr 1.

PMID:
24793679
Items per page

Supplemental Content

Write to the Help Desk